Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy
Article in Seminars in Immunology (October 2022)
The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.
Emerging nanomedicine and prodrug delivery strategies for the treatment of inflammatory bowel disease
Article in Chinese Chemical Letters (October 2022)
Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease
Article in International Journal of Molecular Sciences (June 2022)